PIB TrackerRDI Fund makes its first disbursement
India's Research, Development and Innovation Fund moves from approval to money on the table, with its first electronic tranche reaching a private deep-tech firm.
What happened
- At a Technology Development Board (TDB) programme under the Department of Science & Technology (DST), the first operational milestones of the Research, Development and Innovation (RDI) Fund Scheme were marked together on a single day.
- Agreements for five projects under the RDI Fund were signed, and the first electronic fund disbursement was released.
- ₹50 crore was electronically transferred to Eyestem Research Pvt. Ltd. (Bengaluru) as the first tranche — a cell-therapy company.
- A Compendium / status report on TDB acting as Second Level Fund Manager (SLFM) under the RDI Scheme, covering progress till April 2026, was launched.
- A separate report on a "Quantum-Safe Ecosystem in India" was released, tied to work under the National Quantum Mission.
- Officials noted the call had drawn 124 project proposals worth more than ₹25,000 crore, of which 22 companies were selected.
The event signals that the RDI Fund — announced earlier as a large corpus to crowd private capital into deep-tech and strategic research — has now begun actually moving money, not merely promising it. The disbursement to a regenerative-medicine startup, alongside agreements spanning batteries, satellites, medical devices and unmanned aircraft, illustrates the breadth of sectors the Fund intends to back.
Background & context
India's gross expenditure on R&D has historically hovered around 0.6–0.7% of GDP, far below the levels of comparable economies, and the share borne by the private sector has been unusually low — the public sector and government labs have long carried most of the research load. The RDI Fund is the policy instrument designed to correct that imbalance. Rather than fund laboratories directly, it is built to "crowd in" private and commercial research by lowering the cost and risk of capital for firms working on sunrise and strategic technologies.
The architecture is deliberately two-tiered. The RDI Scheme sits under the Anusandhan National Research Foundation (ANRF) framework for governance, with the corpus parked so that it can be deployed through fund managers rather than disbursed as ordinary grants. A First Level Fund Manager channels money to a set of Second Level Fund Managers (SLFMs) — sector or mandate-specific managers who in turn select and finance individual projects. The Technology Development Board, a statutory body under DST that has financed commercialisation of indigenous technology since the mid-1990s, is the first such SLFM to actually open project-proposal calls and disburse — which is why this particular event carries weight. The instrument is intended to be largely low-interest loan or equity-like capital rather than pure grant, so that public money is recycled rather than spent once.
The five signed projects show the intended spread of the Fund across deep-tech verticals: advanced energy storage, space hardware, regenerative medicine, critical-care medical equipment and defence-relevant aerial systems. The simultaneous release of a quantum-security report links the RDI effort to the parallel National Quantum Mission, positioning research funding and strategic technology sovereignty as two halves of the same agenda.
It helps to place the RDI Fund within the wider family of innovation instruments an aspirant is expected to keep apart. The Anusandhan National Research Foundation is the apex, ANRF-Act-backed body meant to seed, grow and promote research across universities, colleges and laboratories; the RDI Fund is the specific financing corpus operated through managers; the Technology Development Board is the statutory commercialisation financier now wearing the Second Level Fund Manager hat. Alongside these sit production-linked incentive schemes that reward manufacturing scale, and mission-mode programmes such as the National Quantum Mission and the semiconductor and supercomputing missions that target named technologies. The RDI Fund is distinct from all of these: it is neither a manufacturing subsidy nor a single-technology mission, but a horizontal, risk-absorbing pool of patient capital that lets private firms attempt research that markets alone would not finance.
For Prelims
- Full name: Research, Development and Innovation (RDI) Fund / Scheme — an instrument to accelerate private-sector participation in R&D in sunrise and strategic sectors.
- Nodal chain: Department of Science & Technology (DST) → governance linked to the Anusandhan National Research Foundation (ANRF) framework → fund managers (First Level, then Second Level).
- Second Level Fund Manager (SLFM): the Technology Development Board (TDB), a statutory body under DST; it was the first SLFM to launch project-proposal calls under the Scheme.
- First disbursement: ₹50 crore, electronically transferred to Eyestem Research Pvt. Ltd. (Bengaluru), working on first-in-class cell therapies for Geographic Atrophy (a form of age-related macular degeneration) and Idiopathic Pulmonary Fibrosis.
- The five signed projects (carry the full set): (1) e-TRNL Energy (Maharashtra) — advanced Lithium-ion cells on a patented 3-Dimensional Electrode Architecture (3DEA); (2) Dhruva Space (Hyderabad) — "Project Garud", an indigenous modular ~500 kg-class satellite platform; (3) Eyestem Research (Bengaluru) — cell therapy; (4) Noccarc Robotics (Uttar Pradesh) — Intelligent Mobile Life Support System (iMLSS); (5) Endure Air Systems (Noida, UP) — "Project Sabal-200", an indigenous unmanned helicopter carrying payloads exceeding 200 kg.
- Funnel numbers: 124 proposals received, worth more than ₹25,000 crore; 22 companies selected; 15 of them routed through "Bharat Innovates 2026", a global showcase scheduled in Nice, France in June.
- Quantum link: under the National Quantum Mission (NQM), India targeted 2,000 km of quantum-secure communication over eight years and has reportedly achieved nearly half within under four years; the released report covers a "Quantum-Safe Ecosystem", post-quantum cryptography and quantum key distribution.
- TDB profile: the Technology Development Board is a statutory body (established under the Technology Development Board Act, 1995) under DST that provides financial assistance to commercialise indigenous technology and adapt imported technology — making it a natural fit as a fund manager rather than a fresh body created for the RDI Fund.
What it is NOT: The RDI Fund is not a direct grant scheme to government laboratories — it is a fund-manager-routed instrument largely structured as low-interest loans/equity to private and commercial entities. TDB is not a new body created for this Scheme; it is a pre-existing statutory board under DST now serving as a Second Level Fund Manager. The RDI Fund is not the same as the Anusandhan National Research Foundation (ANRF) itself — ANRF is the apex research-funding body and broad framework, while the RDI Fund is a specific corpus/scheme operated through fund managers. It should also not be confused with the National Quantum Mission, which is a separate mission whose quantum-security report merely shared the same release.
Why it matters
The problem the RDI Fund addresses is structural: India spends too little on research as a share of its economy, and what it does spend leans heavily on the public purse. Private firms tend to under-invest in long-horizon, high-uncertainty deep-tech because the payoffs are distant and the risk of failure is high. A patient, fund-manager-routed pool of capital — recycled through loans and equity rather than spent as one-off grants — is meant to bridge that gap, taking on the early risk that commercial lenders avoid. The first disbursement matters precisely because it converts a headline corpus into a working pipeline: agreements signed, money moved, and a status compendium published for accountability. The choice of an existing statutory board (TDB) as the first Second Level Fund Manager also signals an intent to use proven institutional plumbing rather than build new machinery from scratch, which can speed deployment. The spread of the first cohort — energy storage, space, biotech, medical devices, unmanned systems — maps directly onto sectors central to both economic competitiveness and strategic autonomy, the same logic that drives the parallel quantum-security push.